Gail K. Naughton - Nov 3, 2025 Form 4 Insider Report for TherapeuticsMD, Inc. (TXMD)

Role
Director
Signature
/s/ Gail K. Naughton, Ph.D.
Stock symbol
TXMD
Transactions as of
Nov 3, 2025
Transactions value $
$0
Form type
4
Date filed
11/5/2025, 04:17 PM
Previous filing
Feb 20, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Naughton Gail K Director 951 YAMATO ROAD, SUITE 220, BOCA RATON /s/ Gail K. Naughton, Ph.D. 2025-11-05 0001297506

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXMD Restricted Stock Units Award $0 +8.5K $0.00 8.5K Nov 3, 2025 Common Stock 8.5K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. The RSUs will vest on November 3, 2028.